PL360405A1 - Preparat do inhalacji roztworu zawierającego sól tiotropium - Google Patents

Preparat do inhalacji roztworu zawierającego sól tiotropium

Info

Publication number
PL360405A1
PL360405A1 PL01360405A PL36040501A PL360405A1 PL 360405 A1 PL360405 A1 PL 360405A1 PL 01360405 A PL01360405 A PL 01360405A PL 36040501 A PL36040501 A PL 36040501A PL 360405 A1 PL360405 A1 PL 360405A1
Authority
PL
Poland
Prior art keywords
formulation containing
solution formulation
tiotropium salt
inhalative solution
inhalative
Prior art date
Application number
PL01360405A
Other languages
English (en)
Other versions
PL203316B1 (pl
Inventor
Barbara Niklaus-Humke
Christel Schmelzer
Petra Barth
Karin Drechsel
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg
Publication of PL360405A1 publication Critical patent/PL360405A1/pl
Publication of PL203316B1 publication Critical patent/PL203316B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
PL360405A 2000-10-31 2001-10-24 Preparat farmaceutyczny do inhalacji roztworu zawierającego sól tiotropium, zastosowanie preparatu i sposób wytwarzania PL203316B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10054036 2000-10-31

Publications (2)

Publication Number Publication Date
PL360405A1 true PL360405A1 (pl) 2004-09-06
PL203316B1 PL203316B1 (pl) 2009-09-30

Family

ID=7661723

Family Applications (1)

Application Number Title Priority Date Filing Date
PL360405A PL203316B1 (pl) 2000-10-31 2001-10-24 Preparat farmaceutyczny do inhalacji roztworu zawierającego sól tiotropium, zastosowanie preparatu i sposób wytwarzania

Country Status (38)

Country Link
EP (2) EP1837021A3 (pl)
JP (1) JP4344135B2 (pl)
KR (1) KR100853107B1 (pl)
CN (2) CN101292964A (pl)
AR (1) AR038764A1 (pl)
AT (1) ATE373473T1 (pl)
AU (2) AU2002221738B2 (pl)
BG (1) BG66315B1 (pl)
BR (1) BRPI0115076B8 (pl)
CA (1) CA2426074C (pl)
CY (1) CY1107825T1 (pl)
CZ (1) CZ300794B6 (pl)
DE (2) DE10152521A1 (pl)
DK (1) DK1333819T3 (pl)
EA (1) EA007604B1 (pl)
EC (1) ECSP034541A (pl)
EE (1) EE05314B1 (pl)
ES (1) ES2294045T3 (pl)
HR (1) HRP20030338B1 (pl)
HU (1) HU229411B1 (pl)
IL (2) IL155538A0 (pl)
ME (1) ME00244B (pl)
MX (1) MXPA03003742A (pl)
MY (1) MY138940A (pl)
NO (1) NO332519B1 (pl)
NZ (1) NZ526023A (pl)
PE (1) PE20030092A1 (pl)
PL (1) PL203316B1 (pl)
PT (1) PT1333819E (pl)
RS (1) RS50859B (pl)
SA (1) SA01220482B1 (pl)
SI (1) SI1333819T1 (pl)
SK (1) SK286027B6 (pl)
TW (1) TWI293885B (pl)
UA (1) UA78690C2 (pl)
UY (1) UY26989A1 (pl)
WO (1) WO2002036104A2 (pl)
ZA (1) ZA200302922B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10216036A1 (de) * 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
CN1292748C (zh) * 2003-03-05 2007-01-03 南昌弘益科技有限公司 噻托溴铵吸入粉雾剂及其制备工艺
DK2083007T3 (da) * 2003-11-03 2013-07-29 Boehringer Ingelheim Int Tiotropiumsalte, fremgangsmåder til deres fremstilling og lægemiddelformuleringer indeholdende disse
JP5165244B2 (ja) * 2003-11-03 2013-03-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング チオトロピウム塩の製法、チオトロピウム塩及びそれを含有する医薬組成物
WO2006117299A2 (en) 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Novel crystalline forms of tiotropium bromide
EP2044967A1 (de) * 2007-10-01 2009-04-08 Boehringer Ingelheim Pharma GmbH & Co. KG Zerstäuber
CN104306361A (zh) * 2014-09-24 2015-01-28 万特制药(海南)有限公司 一种含噻托溴铵的吸入性溶液
CN111374963A (zh) * 2018-12-31 2020-07-07 天津药业研究院有限公司 一种用于吸入的噻托铵溶液剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE19536902A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen

Also Published As

Publication number Publication date
CA2426074C (en) 2008-12-23
EA007604B1 (ru) 2006-12-29
BRPI0115076B8 (pt) 2021-05-25
CN101292964A (zh) 2008-10-29
NO20031911L (no) 2003-04-29
EA200300482A1 (ru) 2003-12-25
CN1473038A (zh) 2004-02-04
MY138940A (en) 2009-08-28
SK286027B6 (sk) 2008-01-07
EP1837021A2 (de) 2007-09-26
YU33003A (sh) 2006-05-25
ECSP034541A (es) 2003-05-26
MXPA03003742A (es) 2004-10-15
HUP0301378A2 (hu) 2003-10-28
BG107727A (bg) 2004-11-30
PT1333819E (pt) 2007-10-29
CY1107825T1 (el) 2013-06-19
BR0115076A (pt) 2003-07-29
JP2004512357A (ja) 2004-04-22
PL203316B1 (pl) 2009-09-30
SK5272003A3 (en) 2003-10-07
EP1333819B1 (de) 2007-09-19
DE50113037D1 (de) 2007-10-31
HUP0301378A3 (en) 2005-12-28
EP1333819A2 (de) 2003-08-13
UY26989A1 (es) 2002-06-20
SI1333819T1 (sl) 2007-12-31
KR100853107B1 (ko) 2008-08-21
UA78690C2 (uk) 2007-04-25
AR038764A1 (es) 2005-01-26
DE10152521A1 (de) 2002-07-11
AU2173802A (en) 2002-05-15
CZ20031486A3 (cs) 2003-08-13
EE200300203A (et) 2003-10-15
EE05314B1 (et) 2010-08-16
ATE373473T1 (de) 2007-10-15
HK1060524A1 (zh) 2004-08-13
MEP40408A (en) 2011-02-10
NO332519B1 (no) 2012-10-08
AU2002221738B2 (en) 2007-01-11
SA01220482B1 (ar) 2007-07-31
BRPI0115076B1 (pt) 2016-07-26
ES2294045T3 (es) 2008-04-01
IL155538A0 (en) 2003-11-23
HRP20030338B1 (en) 2011-09-30
IL155538A (en) 2008-11-26
DK1333819T3 (da) 2007-12-03
WO2002036104A2 (de) 2002-05-10
HU229411B1 (en) 2013-12-30
PE20030092A1 (es) 2003-03-24
ME00244B (me) 2011-05-10
JP4344135B2 (ja) 2009-10-14
CN100396285C (zh) 2008-06-25
EP1837021A3 (de) 2008-03-19
KR20030060926A (ko) 2003-07-16
WO2002036104A3 (de) 2002-08-01
CA2426074A1 (en) 2002-05-10
ZA200302922B (en) 2004-04-22
BG66315B1 (bg) 2013-04-30
NO20031911D0 (no) 2003-04-29
HRP20030338A2 (en) 2005-04-30
CZ300794B6 (cs) 2009-08-12
TWI293885B (en) 2008-03-01
RS50859B (sr) 2010-08-31
NZ526023A (en) 2005-05-27

Similar Documents

Publication Publication Date Title
IL147553A0 (en) Moxifloxacin formulation containing common salt
EG24139A (en) New inhalable powder containing tiotropium
EG24478A (en) New inhalable powder containing tiotropium
IL153882A0 (en) Valsartan salts
EG24137A (en) Tropane derivatives useful in therapy
PL364223A1 (pl) Sole farmaceutyczne
PL358020A1 (pl) Nowe zastosowanie kompleksowych fluorków
IL155676A0 (en) Inhalative solution formulation containing a tiotropium salt
GB0011807D0 (en) Formulation for inhalation
AU2002221741A1 (en) Inhalative solution formulation containing a tiotropium salt
IL155538A0 (en) Inhalative solution formulation containing a tiotropium salt
PL371204A1 (pl) Preparat w postaci aerozolu do inhalacji zawierający sól tiotropium
AU2002221738A1 (en) Inhalative solution formulation containing a tiotropium salt
HUP0300808A3 (en) Fungicidal formulation containing triazolopyridine derivative
AP2003002783A0 (en) Medicament containing activted antihtrombin iii
EP1406592A4 (en) MEDICAL AEROSOL FORMULATION WITH PAIR SALT / ION
EP1429732A4 (en) CORE FORMULATION
GB0013400D0 (en) A formulation
GB0015079D0 (en) Solution for pharmaceutical use
TW459479U (en) Agent dispenser for aquarium
CA91072S (en) Salt platform
ZA200508282B (en) Method of preparing a formulation containing a microdosed active principle